Showing results (71-80 of 135) with videos related to
Sort By:
Pageof 14
Cell Reports|November 23, 2017
Impediment of Replication Forks by Long Non-coding RNA Provokes Chromosomal Rearrangements by Error-Prone RestartTakaaki Watanabe, Michael Marotta, Ryusuke Suzuki, et al.European Journal of Medicinal Chemistry|October 8, 2025
Novel PROTACs targeting tissue transglutaminase (TG2) suppress tumorigenicity of ovarian cancer cellsAndres Valdivia, Joshua L Zhu, Vanessa Hernandez, et al.Cancer & Metabolism|February 12, 2015
Succinate dehydrogenase inhibition leads to epithelial-mesenchymal transition and reprogrammed carbon metabolismPaul-Joseph P Aspuria, Sophia Y Lunt, Leif Väremo, et al.Molecular Metabolism|April 23, 2026
Oleic Acid Fuels Cisplatin-Resistant Ovarian Cancer Through FABP4-Driven Lipid UptakeAna Maria Isac, Andres Valdivia, Didi Zha, et al.The Journal of Clinical Investigation|October 1, 2025
SOX9 drives a stem-like transcriptional state and platinum resistance in high-grade serous ovarian cancerAlexander J Duval, Fidan Seker-Polat, Magdalena Rogozinska, et al.Cancer Research|October 22, 2009
A role for BRCA1 in uterine leiomyosarcomaDeyin Xing, George Scangas, Mai Nitta, et al.Scientific Reports|December 6, 2025
Combined inhibition of NAD synthesis and C-terminal binding protein cooperatively induces cell death and inhibits growth of high grade serous ovarian carcinomaKranthi Kumar Chougoni, Jacqueline West, Nicholette St Martin, et al.Plos One|April 28, 2010
Distinct expression levels and patterns of stem cell marker, aldehyde dehydrogenase isoform 1 (ALDH1), in human epithelial cancersShan Deng, Xiaojun Yang, Heini Lassus, et al.Cancer Research|July 12, 2011
CXCL12/CXCR4 blockade induces multimodal antitumor effects that prolong survival in an immunocompetent mouse model of ovarian cancerElda Righi, Satoshi Kashiwagi, Jianping Yuan, et al.Cell Reports|December 29, 2021
Human iPSC-derived fallopian tube organoids with BRCA1 mutation recapitulate early-stage carcinogenesisNur Yucer, Rodney Ahdoot, Michael J Workman, et al.Pageof 14